CBA has been a popular inclusion in many Australian investors’ portfolios. But has its surge been too good for too long?

In this wire, we crunch the data on the country's top-performing Aussie equities funds and examine their 2025 positioning.

We look at data, the economic cycle, and outlooks from fund managers and research houses in an attempt to answer that question.

As well as share price re-rates among producers, expect more M&A like that being undertaken by Minerals 260 and Sipa.

Selective stock-picking and conviction drove HB Biotech’s strong 2024 performance. Read our insights on navigating today’s biotech market.

We are particularly focused on the growing demand for energy and critical minerals as key themes.

Here you will find your top-tipped ASX income stock picks from the 2025 Outlook Series Survey.

Spheria's Brittany Isakka shares the thought process her team uses when investing in and avoiding small and mid-caps.

The AMP team have put together a “wish list” for 2025 of the top five things we hope will happen.

The December CPI print delivered a much-needed downside surprise, relieving some of the market anxiety that the U.S. economy is at the beginning of a second inflation...

There were massive winners and massive losers on the ASX in 2024. We bring you 2025 outlooks from three major brokers: Buy, hold or sell?

And the stocks you and the experts tipped for exposure in the 2025 Outlook Series Survey.

Avoiding big losses is a sure way to help compound your wealth. Nine professional investors share the stocks they're avoiding in 2025

As part of the 2025 Outlook Series, Livewire interviewed 10 fund managers. Here, we share the full interview with Ellerston's James Barker.

In this wire, we discuss the value that can be derived from investing with a top-performing CEO

While on average, the top 10 returned over 70%.

Plus, why he's fishing in life insurance for a portfolio idea in 2025.

We think the potential for investors who ascribe to our top-down thesis to generate above-average returns is still compelling.